X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (31822) 31822
Book Review (8735) 8735
Publication (1567) 1567
Book Chapter (184) 184
Newsletter (104) 104
Magazine Article (95) 95
Book / eBook (89) 89
Conference Proceeding (74) 74
Newspaper Article (58) 58
Web Resource (25) 25
Dissertation (9) 9
Trade Publication Article (6) 6
Data Set (3) 3
Reference (2) 2
Paper (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (28172) 28172
humans (27101) 27101
platelet aggregation inhibitors - therapeutic use (18104) 18104
male (13283) 13283
female (11619) 11619
middle aged (9066) 9066
aged (8119) 8119
aspirin - therapeutic use (6570) 6570
cardiac & cardiovascular systems (5871) 5871
animals (5694) 5694
treatment outcome (5572) 5572
aspirin (5332) 5332
ticlopidine - analogs & derivatives (5169) 5169
risk factors (5087) 5087
abridged index medicus (4993) 4993
ticlopidine - therapeutic use (4563) 4563
adult (4305) 4305
peripheral vascular disease (4157) 4157
anticoagulants - therapeutic use (4003) 4003
clopidogrel (3954) 3954
platelet aggregation - drug effects (3950) 3950
hematology (3799) 3799
platelet aggregation inhibitors - adverse effects (3764) 3764
pharmacology & pharmacy (3701) 3701
thrombosis (3271) 3271
platelet aggregation inhibitors - administration & dosage (3248) 3248
platelet aggregation inhibitors - pharmacology (3221) 3221
drug therapy, combination (3178) 3178
platelets (2871) 2871
time factors (2851) 2851
blood platelets - drug effects (2707) 2707
blood platelets (2701) 2701
stents (2553) 2553
medicine, general & internal (2421) 2421
percutaneous coronary intervention (2415) 2415
aged, 80 and over (2371) 2371
stroke (2367) 2367
fibrinolytic agents - therapeutic use (2282) 2282
risk (2193) 2193
drug therapy (2152) 2152
prevention (2151) 2151
myocardial-infarction (2139) 2139
acute coronary syndromes (2098) 2098
care and treatment (2059) 2059
prospective studies (2038) 2038
aggregation (1983) 1983
surgery (1980) 1980
mortality (1970) 1970
cardiology (1955) 1955
therapy (1936) 1936
platelet aggregation (1893) 1893
antiplatelet therapy (1876) 1876
retrospective studies (1839) 1839
blood platelets - metabolism (1832) 1832
platelet glycoprotein gpiib-iiia complex - antagonists & inhibitors (1820) 1820
analysis (1801) 1801
anticoagulants (1723) 1723
myocardial infarction - drug therapy (1709) 1709
follow-up studies (1692) 1692
heart attacks (1678) 1678
acute myocardial-infarction (1662) 1662
cardiovascular disease (1650) 1650
angioplasty, balloon, coronary (1619) 1619
risk assessment (1611) 1611
stroke - prevention & control (1586) 1586
medicine & public health (1579) 1579
aspirin - administration & dosage (1543) 1543
dose-response relationship, drug (1539) 1539
randomized controlled trials as topic (1522) 1522
cardiovascular (1497) 1497
health aspects (1476) 1476
research (1472) 1472
hemorrhage - chemically induced (1470) 1470
thrombosis - prevention & control (1453) 1453
rats (1442) 1442
coronary heart disease (1437) 1437
disease (1393) 1393
trial (1354) 1354
inhibition (1325) 1325
angioplasty (1320) 1320
aspirin - adverse effects (1318) 1318
mice (1303) 1303
clinical neurology (1288) 1288
myocardial infarction - therapy (1277) 1277
cardiac patients (1267) 1267
ticlopidine - adverse effects (1255) 1255
acute coronary syndrome - drug therapy (1238) 1238
secondary prevention (1235) 1235
clinical trials as topic (1220) 1220
activation (1207) 1207
recurrence (1179) 1179
cardiovascular diseases (1174) 1174
anticoagulants - adverse effects (1169) 1169
platelet-aggregation (1168) 1168
platelet activation (1129) 1129
coronary angiography (1121) 1121
blood platelets - physiology (1120) 1120
heparin - therapeutic use (1112) 1112
atherosclerosis (1106) 1106
ticlopidine - administration & dosage (1104) 1104
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (29467) 29467
German (623) 623
French (563) 563
Spanish (344) 344
Russian (280) 280
Japanese (272) 272
Italian (219) 219
Chinese (155) 155
Polish (90) 90
Dutch (55) 55
Portuguese (41) 41
Hungarian (31) 31
Czech (29) 29
Turkish (27) 27
Danish (21) 21
Swedish (21) 21
Hebrew (15) 15
Ukrainian (12) 12
Norwegian (11) 11
Finnish (10) 10
Korean (10) 10
Lithuanian (9) 9
Serbian (9) 9
Romanian (6) 6
Croatian (5) 5
Icelandic (4) 4
Slovak (3) 3
Bosnian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2011, Volume 378, Issue 9798, pp. 1231 - 1243
Summary Background Although most cardiovascular disease occurs in low-income and middle-income countries, little is known about the use of effective secondary... 
Internal Medicine | STROKE | MEDICINE, GENERAL & INTERNAL | RISK-FACTORS | THERAPY | MYOCARDIAL-INFARCTION | AVAILABILITY | HEART-FAILURE | SELF-REPORT | ACUTE CORONARY SYNDROMES | MEDICINES | VALIDITY | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Data Collection | Secondary Prevention | Stroke - drug therapy | Urban Population | Antihypertensive Agents - therapeutic use | Drug Utilization | Cardiovascular Agents - therapeutic use | Developed Countries | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Rural Population | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Coronary Disease - drug therapy | Adult | Female | Aged | Developing Countries | Platelet Aggregation Inhibitors - therapeutic use | Adrenergic beta-Antagonists - therapeutic use | Care and treatment | Research | Cardiovascular diseases | Health aspects | Cardiovascular agents | Studies | Low income groups | Stroke | Households | Socioeconomic factors | Data collection | Cardiovascular disease | Epidemiology | Economic development | Community | Drug use | Index Medicus | Abridged Index Medicus | Antihypertensive Agents/therapeutic use | Angiotensin-Converting Enzyme Inhibitors/therapeutic use | Cardiovascular Agents/therapeutic use | Coronary Disease/drug therapy | Cardiovascular Diseases/prevention & control | Platelet Aggregation Inhibitors/therapeutic use | Stroke/drug therapy | MEDICIN OCH HÄLSOVETENSKAP | Adrenergic beta-Antagonists/therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use | MEDICAL AND HEALTH SCIENCES
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2008, Volume 359, Issue 12, pp. 1238 - 1251
In this large clinical trial, aspirin plus extended-release dipyridamole was found to have an efficacy similar to that of clopidogrel in the prevention of... 
ISSUES | MEDICINE, GENERAL & INTERNAL | PLACEBO | DESIGN | TICLOPIDINE | WARFARIN | TRANSIENT ISCHEMIC ATTACK | DOUBLE-BLIND | PREVENTION | REGIMENS | NON-INFERIORITY TRIALS | Myocardial Infarction - epidemiology | Benzoates - therapeutic use | Ticlopidine - therapeutic use | Humans | Middle Aged | Male | Risk | Secondary Prevention | Aspirin - administration & dosage | Vascular Diseases - mortality | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Aspirin - adverse effects | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Dipyridamole - adverse effects | Female | Stroke - epidemiology | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Dipyridamole - therapeutic use | Benzimidazoles - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Brain Ischemia - epidemiology | Stroke - prevention & control | Double-Blind Method | Kaplan-Meier Estimate | Proportional Hazards Models | Brain Ischemia - prevention & control | Factor Analysis, Statistical | Stroke - drug therapy | Ticlopidine - analogs & derivatives | Aged | Hemorrhage - chemically induced | Delayed-Action Preparations | Stroke (Disease) | Aspirin | Usage | Care and treatment | Dipyridamole | Clopidogrel | Health aspects | Stroke | Index Medicus | Abridged Index Medicus | Recurrence | Brain Ischemia | Benzimidazoles | Follow-Up Studies | Neurons and Cognition | Cognition | Hemorrhage | Drug Delivery Systems | Life Sciences | Angiotensin II Type 1 Receptor Blockers | Angiotensin-Converting Enzyme Inhibitors | Vascular Diseases | Mental Status Schedule | Retrospective Studies | Severity of Illness Index | Disability Evaluation | Benzoates | Drug Administration Schedule | International Cooperation | Ticlopidine | Myocardial Infarction | Platelet Aggregation Inhibitors | Santé publique et épidémiologie | Original | Dipyridamole/adverse effects/therapeutic use | Angiotensin-Converting Enzyme Inhibitors/therapeutic use | Recurrence/prevention & control | Benzoates/therapeutic use | Brain Ischemia/epidemiology/prevention & control | MEDICIN OCH HÄLSOVETENSKAP | Platelet Aggregation Inhibitors/administration & dosage/adverse | Combination | MEDICAL AND HEALTH SCIENCES | Aspirin/administration & dosage/adverse effects | Myocardial Infarction/epidemiology | Factor Analysis | Benzimidazoles/therapeutic use | Drug Therapy | Ticlopidine/adverse effects/analogs & derivatives/therapeutic use | effects/therapeutic use | Vascular Diseases/mortality | Hemorrhage/chemically induced | Stroke/drug therapy/epidemiology/prevention & control | Statistical | Kaplan-Meiers Estimate
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2017, Volume 377, Issue 14, pp. 1319 - 1330
Journal Article